International Cannabis Weekly
Prohibition Partners

The independent cannabis research house

The global cannabis market, sized, tracked and defensible.

Flagship reports and market-sizing data packs covering 31 European markets and 4 international benchmarks — five-year forecasts built and defended by the analysts behind the Global Medical Cannabis Market Review and The European Cannabis Report.

Browse reports & data Request bespoke data

Trusted by Diageo, KPMG, Novartis, Barclays & Bloomberg

One group, five ways to work with us

This year’s essential editions

All reports & data

Global Medical Cannabis Market Review

Report · 2026

From £1,265

The European Cannabis Report: 10th Edition

Report · 2026

From £1,429

UK Medical Cannabis Market Update 2026

Report · 2026

£1,249

The German Cannabis Market Report

Report · 2026

£399

Cited in boardrooms, legal proceedings & government briefings since 2017.

DIAGEOKPMGCoca-ColaBarclaysNovartisJohnson & JohnsonBloomberg

Intelligence for every decision-maker

Whatever you need to decide, start from the same credible source.

European medical sales

€1.29bn → €2.2bn

2025 actual → 2027 forecast · to 2030 in the data packs

The Capital Allocator

VC, PE and institutional investors — defensible market sizing, forecasts and risk framing for the deal.

Market status

  • GermanyMed · LegalAdult · Legal
  • United KingdomMed · LegalAdult · Illegal
  • PolandMed · LegalAdult · Illegal

The Corporate Strategist

Strategy leads at FMCG, pharma and operators scoping market entry and expansion.

Regulatory outlook · Germany

  1. 2026Pillar two: commercial pilot programmes

The Policy Professional

Regulators, trade bodies and legal teams who need the commercial evidence base.

Market Intelligence

Country-by-country medical sales and patient numbers, 2025–2027, from the dataset behind the Global Medical Cannabis Market Review and The European Cannabis Report. Profiles and the 2027 outlook are free to read; forecasts to 2030 are in the data packs.

Explore all 28 market profiles

Germany

Medical

€836.4m

medical sales, 2025

2027 forecast
€1.48bn
Patients, 2025
720,041
Market profile

UK

Medical

€265.4m

medical sales, 2025

2027 forecast
€430.1m
Patients, 2025
91,487
Market profile

Italy

Medical

€72.2m

medical sales, 2025

2027 forecast
€99.6m
Patients, 2025
49,732
Market profile

Source: Prohibition Partners — Global Medical Cannabis Market Review (2026, updated April 2026) & The European Cannabis Report (2025).

Track regulation across every market

Our legislation map covers medical and adult-use status, market size and access pathways country by country — free to read, including the full sizing and forecasts.

Explore the mapBrowse reports & data
What changedView the radar
Adult-use legalAdult-use pilotMedical legalMedical limited / proposed
Open the interactive map

Bespoke research & consultancy

Commission the exact intelligence your decision needs.

Market entry, sizing, due diligence and custom analysis — delivered by the team behind PP’s research, scoped to your question and timeline.

Request a brief

1 Tell us the objective & markets

2 Deliverable, timeline & budget

3 We scope it within 48 hours

Start a brief

A decade of published research

The European Cannabis Report, market reviews, datasets and white papers — every edition sold individually, licensed for internal use.

Browse the library

International Cannabis Weekly

One curated brief a week on the developments that move the market — read by senior operators, investors and policymakers.